Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Rossi

Showing results (211-220 of 259) with videos related to

Pageof 26
Sort By:
American Journal of Hematology|November 4, 2020
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimenPatrizia Chiusolo, Stefania Bregante, Sabrina Giammarco, et al.
British Journal of Haematology|February 22, 2021
Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective studyElisa Lucchini, Francesca Palandri, Stefano Volpetti, et al.
Thrombosis Research|November 30, 2019
Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 yearsFrancesca Palandri, Cristina Santoro, Monica Carpenedo, et al.
Haematologica|February 13, 2008
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatmentsValerio De Stefano, Tommaso Za, Elena Rossi, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2024
Distinguishing Genetic Alterations Versus (Epi)Mutations in Silver-Russell Syndrome and Focus on the IGF1R GeneAlessandro Vimercati, Pierpaola Tannorella, Sara Guzzetti, et al.
American Journal of Hematology|October 7, 2017
Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centersSilvia Cantoni, Monica Carpenedo, Maria Gabriella Mazzucconi, et al.
American Journal of Hematology|April 5, 2012
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPNElisabetta Antonioli, Paola Guglielmelli, Lisa Pieri, et al.
The New England Journal of Medicine|December 9, 2025
Ianalumab plus Eltrombopag in Immune ThrombocytopeniaAdam Cuker, Thomas Stauch, Nichola Cooper, et al.
Cancers|November 13, 2025
The Strange Case of Functional High-Risk Multiple Myeloma Patients: Is It Possible to Identify Them in Clinical Practice?Sonia Morè, Massimo Offidani, Laura Corvatta, et al.
Hemasphere|December 31, 2025
Health-related quality of life and symptom profile of patients with <i>BCR::ABL1</i>-negative myeloproliferative neoplasms: Real-world evidence from the GIMEMA-PROPHECY observational studyGiovanni Caocci, Alessandro Costa, Francesca Palandri, et al.
Pageof 26

Showing results (211-220 of 259) with videos related to

Sort By:
Pageof 26
American Journal of Hematology|November 4, 2020
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimenPatrizia Chiusolo, Stefania Bregante, Sabrina Giammarco, et al.
British Journal of Haematology|February 22, 2021
Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective studyElisa Lucchini, Francesca Palandri, Stefano Volpetti, et al.
Thrombosis Research|November 30, 2019
Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 yearsFrancesca Palandri, Cristina Santoro, Monica Carpenedo, et al.
Haematologica|February 13, 2008
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatmentsValerio De Stefano, Tommaso Za, Elena Rossi, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2024
Distinguishing Genetic Alterations Versus (Epi)Mutations in Silver-Russell Syndrome and Focus on the IGF1R GeneAlessandro Vimercati, Pierpaola Tannorella, Sara Guzzetti, et al.
American Journal of Hematology|October 7, 2017
Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centersSilvia Cantoni, Monica Carpenedo, Maria Gabriella Mazzucconi, et al.
American Journal of Hematology|April 5, 2012
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPNElisabetta Antonioli, Paola Guglielmelli, Lisa Pieri, et al.
The New England Journal of Medicine|December 9, 2025
Ianalumab plus Eltrombopag in Immune ThrombocytopeniaAdam Cuker, Thomas Stauch, Nichola Cooper, et al.
Cancers|November 13, 2025
The Strange Case of Functional High-Risk Multiple Myeloma Patients: Is It Possible to Identify Them in Clinical Practice?Sonia Morè, Massimo Offidani, Laura Corvatta, et al.
Hemasphere|December 31, 2025
Health-related quality of life and symptom profile of patients with <i>BCR::ABL1</i>-negative myeloproliferative neoplasms: Real-world evidence from the GIMEMA-PROPHECY observational studyGiovanni Caocci, Alessandro Costa, Francesca Palandri, et al.
Pageof 26